1990
DOI: 10.1097/00006254-199003000-00017
|View full text |Cite
|
Sign up to set email alerts
|

Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
52
0
5

Year Published

2002
2002
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 38 publications
(62 citation statements)
references
References 0 publications
5
52
0
5
Order By: Relevance
“…Evaluation of the ovaries and measurement of ovarian volumes of all cases were performed by transvaginal ultrasound using a Siemens Sonoline Adara (Siemens Healthcare) 6.5 MHz transvaginal probe. Regularly menstruating women were scanned in the early follicular phase (cycle days [3][4][5]. Progestin was administered to the PCOS cases with oligomenorrhea or amenorrhea.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Evaluation of the ovaries and measurement of ovarian volumes of all cases were performed by transvaginal ultrasound using a Siemens Sonoline Adara (Siemens Healthcare) 6.5 MHz transvaginal probe. Regularly menstruating women were scanned in the early follicular phase (cycle days [3][4][5]. Progestin was administered to the PCOS cases with oligomenorrhea or amenorrhea.…”
Section: Methodsmentioning
confidence: 99%
“…Although the main source of androgen is the ovary [4], adrenal androgens such as dehydroepiandrosterone sulfate (DHEAS) [5], are also elevated in 36%-50% of women with PCOS. In previous studies, it was shown that high DHEAS is associated with a good metabolic profile and presence of acne more than high total testosterone (TT) [6].…”
Section: Introductionmentioning
confidence: 99%
“…Spontaneous LH pulse frequency is increased, which is particularly striking in overnight studies since these women typically lack the normal nocturnal slowing of pulse frequency that is the residual effect of ovulation in the previous cycle (McCartney et al, 2002; Taylor et al, 1997). LH pulse amplitude is also increased (Kazer et al, 1987; Waldstreicher et al, 1988), which is reflected in the size of the pulse induced promptly by GnRH (Arroyo et al, 1997) or GnRH agonist administration (Barnes et al, 1989). LH secreted early (30–60 min) in response to GnRH or GnRH agonist injection subcutaneously represents the readily releasable gonadotrope pool of preformed LH (GnRH agonist, being long-acting, then stimulates synthesis and release of a second, slowly releasable gonadotropin pool) (Bremner and Paulsen, 1974; Redding et al, 1972; Rosenfield et al, 1996; Zimmer et al, 2010).…”
Section: Relationship Of Nutritional Status To Neuroendocrine Funcmentioning
confidence: 99%
“…The test has been used in the setting of PCOS. 56 The original test was performed using nafarelin, 56 but other GnRH agonists may be used with no substantial differences. Generally, leuprolide (500 or 1000 μg) is given subcutaneously in the morning between the fifth and the eighth day of the cycle.…”
Section: Gonadotropin-releasing Hormone-agonist Testmentioning
confidence: 99%